FdaApplication
ANDA 216145
Identifiers
- fda_app_no: ANDA216145
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2022-12-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZINC SULFATE | ZINC SULFATE | EQ 30MG BASE/10ML (EQ 3MG BASE/ML) | SOLUTION;INTRAVENOUS |
| ZINC SULFATE | ZINC SULFATE | EQ 10MG BASE/10ML (EQ 1MG BASE/ML) | SOLUTION;INTRAVENOUS |
| ZINC SULFATE | ZINC SULFATE | EQ 25MG BASE/5ML (EQ 5MG BASE/ML) | SOLUTION;INTRAVENOUS |
3 products